HypomimiaCoach: An AU-based Digital Therapy System for Hypomimia Detection & Rehabilitation with Parkinson's Disease
Hypomimia is a non-motor symptom of Parkinson's disease that manifests as delayed facial movements and expressions, along with challenges in articulation and emotion. Currently, subjective evaluation by neurologists is the primary method for hypomimia detection, and conventional rehabilitation...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Hypomimia is a non-motor symptom of Parkinson's disease that manifests as
delayed facial movements and expressions, along with challenges in articulation
and emotion. Currently, subjective evaluation by neurologists is the primary
method for hypomimia detection, and conventional rehabilitation approaches
heavily rely on verbal prompts from rehabilitation physicians. There remains a
deficiency in accessible, user-friendly and scientifically rigorous assistive
tools for hypomimia treatments. To investigate this, we developed
HypomimaCoach, an Action Unit (AU)-based digital therapy system for hypomimia
detection and rehabilitation in Parkinson's disease. The HypomimaCoach system
was designed to facilitate engagement through the incorporation of both relaxed
and controlled rehabilitation exercises, while also stimulating initiative
through the integration of digital therapies that incorporated traditional face
training methods. We extract action unit(AU) features and their relationship
for hypomimia detection. In order to facilitate rehabilitation, a series of
training programmes have been devised based on the Action Units (AUs) and
patients are provided with real-time feedback through an additional AU
recognition model, which guides them through their training routines. A pilot
study was conducted with seven participants in China, all of whom exhibited
symptoms of Parkinson's disease hypomimia. The results of the pilot study
demonstrated a positive impact on participants' self-efficacy, with favourable
feedback received. Furthermore, physician evaluations validated the system's
applicability in a therapeutic setting for patients with Parkinson's disease,
as well as its potential value in clinical applications. |
---|---|
DOI: | 10.48550/arxiv.2410.09772 |